Abstract
We evaluated C-reactive protein increases after implantation of bare metal stents in 200 patients and sirolimus-eluting stents in 100 patients. The magnitude of change in C-reactive protein was comparable between groups. Clinical follow-up showed a relation between the postprocedural C-reactive protein increase and outcome that was significant in the bare metal stent group, which accounted for the most of events, but not in the sirolimus-eluting stent group.
MeSH terms
-
Aged
-
Angina, Unstable / blood
-
Angina, Unstable / mortality
-
Angina, Unstable / therapy*
-
C-Reactive Protein / metabolism*
-
Coronary Disease / blood
-
Coronary Disease / mortality
-
Coronary Disease / therapy*
-
Coronary Restenosis / blood
-
Coronary Restenosis / mortality
-
Coronary Restenosis / prevention & control
-
Disease-Free Survival
-
Female
-
Follow-Up Studies
-
Humans
-
Male
-
Metals*
-
Middle Aged
-
Outcome and Process Assessment, Health Care
-
Prognosis
-
Sirolimus / administration & dosage*
-
Statistics as Topic
-
Stents*
-
Survival Rate
Substances
-
Metals
-
C-Reactive Protein
-
Sirolimus